Evidence map›Paper›PMID 27803937›Full record

Trial reportJournal of diabetes research2016

Shankaranarayanan Jeykodi, Jayant Deshpande, Vijaya Juturu

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of diabetes research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Reduced postprandial bone resorption and greater rise in GLP-1 in overweight and obese individuals after an α-glucosidase inhibitor: a double-blinded randomized crossover trial.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2021
    Trial
  2. Trial
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Shankaranarayanan JeykodiResearch and Development, OmniActive Health Technologies Ltd., Mumbai, India.
Jayant DeshpandeResearch and Development, OmniActive Health Technologies Inc., Prince Edward Island, Canada.
Vijaya JuturuScientific and Clinical Affairs, OmniActive Health Technologies Inc., Morristown, NJ, USA.ORCID 0000-0002-7397-715X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thirty-five healthy subjects were randomly assigned to different doses of

Indexed as

SalaciaAdultBlood GlucoseCross-Over StudiesDouble-Blind MethodHealthy VolunteersHumansInsulinMalePlant ExtractsPostprandial PeriodYoung AdultBlood GlucoseInsulinPlant Extracts

Identifiers

PMID27803937
PMCPMC5075619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.